GlaxoSmithKline PLC Logo

GlaxoSmithKline PLC

A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.

GSK | IL

Overview

Corporate Details

ISIN(s):
GB00BN7SWP63 (+1 more)
LEI:
5493000HZTVUYLO1D793
Country:
United Kingdom
Address:
79 NEW OXFORD STREET, WC1A 1DG LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GSK is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company focuses on the discovery, development, and manufacturing of innovative vaccines and specialty medicines. Its core research and development efforts are concentrated in four therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham, GSK has since sharpened its focus on biopharmaceuticals, notably after the 2022 demerger of its consumer healthcare business. The company is committed to improving global health by making its products accessible and affordable worldwide through strategic partnerships and access programs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 08:00
Transaction in Own Shares
Transaction in Own Shares
English 1.2 MB
2025-10-02 08:00
Transaction in Own Shares
Transaction in Own Shares
English 1.1 MB
2025-10-01 16:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 5.3 KB
2025-10-01 08:00
Transaction in Own Shares
Transaction in Own Shares
English 636.6 KB
2025-09-29 08:00
Board/Management Information
GSK appoints CEO designate
English 29.1 KB
2025-09-22 16:30
Director's Dealing
Director/PDMR Shareholding
English 76.7 KB
2025-09-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 183.8 KB
2025-09-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 1.6 MB
2025-09-17 08:00
Regulatory News Service
GSK US Investment Announcement
English 19.9 KB
2025-09-17 08:00
Transaction in Own Shares
Transaction in Own Shares
English 705.5 KB
2025-09-16 08:00
Transaction in Own Shares
Transaction in Own Shares
English 2.6 MB
2025-09-15 08:00
Transaction in Own Shares
Transaction in Own Shares
Japanese 2.0 MB
2025-09-11 08:00
Transaction in Own Shares
Transaction in Own Shares
English 653.1 KB
2025-09-10 16:30
Director's Dealing
Director/PDMR Shareholding
English 91.7 KB
2025-09-10 08:00
Transaction in Own Shares
Transaction in Own Shares
English 423.3 KB

Automate Your Workflow. Get a real-time feed of all GlaxoSmithKline PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GlaxoSmithKline PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD
GC CELL CORPORATION Logo
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
South Korea 144510
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea 082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea 229000
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea 109820
GeneOne Life Science, Inc. Logo
Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.
South Korea 011000
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.